
Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma
A new class of drugs that inhibits a "master switch" involved in the vast majority
A new class of drugs that inhibits a "master switch" involved in the vast majority
A new class of drugs that inhibits a "master switch" involved in the vast majority
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue
(HealthDay)—High levels of physical activity may lower the risk for developing lymphoma, according to a
Researchers at The University of Texas MD Anderson Cancer Center have identified molecular and cellular
Our teeth take thousands of bites per day, and understanding exactly what holds them in
Melanoma is a deadly form of skin cancer that has been increasing in the U.S.
Epithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to
Cancer treatment often involves a combination of chemotherapy and radiotherapy. Chemotherapy uses medication to stop
Researchers at Tel Aviv University, led by Prof. Carmit Levy and Dr. Tamar Golan of